Kim et al. 1 conclude that somatic gene recombination (SGR) and amyloid precursor protein (APP) genomic complementary DNAs (gencDNAs) in brain are plasmid PCR artifacts and do not naturally exist. We disagree. Lee et al. 2 presented a total of nine distinct approaches, in addition to three from a prior publication 3 , which support the existence of APP gencDNAs, and seven of these are independent of APP PCR ( Table 1) . Contamination in our pull-down dataset was identified after publication of Lee et al. 2 ; however subsequent analyses showed that the contamination does not change any of our conclusions including those in our other publications (see below) 3, 4 . Notably, alterations of APP gencDNA number and form by Alzheimer's disease (AD) and cell-type cannot be explained by plasmid contamination and PCR artifact. Here we provide data and discussion, which address the three analyses used by Kim et al. 1 to reach their conclusions: plasmid contaminant identification, plasmid PCR, and single-cell sequencing.
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Ten uncontaminated whole-exome pull-down datasets identify APP gencDNAs
An APP plasmid contaminant (pGEMT APP) in our single pull-down dataset was found, however we could not definitively determine which APP exon::exon reads were due to gencDNAs vs. contamination, especially in view of the 11 other uncontaminated approaches that had independently identified APP gencDNAs. We therefore pursued confirmatory data through three additional pull-down experiments on seven human brain samples, using new reagents (e.g., Agilent
Human All Exon Kit (V6)). The resulting three datasets are free of APP plasmid contamination by both VecScreen 5 and subsequent use of Kim et al.'s Vecuum script 6 : critically, all of our uncontaminated datasets contain APP gencDNA sequences (Figure 1a,b) . We also analyzed an independent whole-exome pull-down study from an unrelated laboratory (Park et al.) 7 and identified APP gencDNA sequences in five different sporadic Alzheimer's disease (SAD) brains and two blood samples: again all are plasmid-free by Vecuum 6 (Figure 1a-e ). Notably, Park et al.'s pull-down contained probes recognizing 5' and 3' UTRs and we identified APP UTR sequences paired with reads containing APP gencDNA exon::exon junctions (Figure 1d,e ). Thus, uncontaminated pull-down datasets from two different laboratories have now identified APP gencDNA sequences, including some with an UTR, all of which are consistent with our 11 unchallenged approaches that support the biological existence of APP gencDNAs ( Table 1) . Table 1) . Critically, SMRT sequencing identified 11 single nucleotide variations that are considered pathogenic in familial AD, which were only present in our SAD samples, while none exist as plasmids in our laboratory: contamination cannot explain these results. Supplementary Table   1 ). We wish to note that micro-homology regions within APP exons are intrinsic to APP's DNA sequence, and that micro-homology mediated repair mechanisms involve DNA polymerases 10,11 .
Detection of gencDNAs without use of APP PCR

Non-biological data are generated by PCR of APP plasmids
Kim et al.'s PCR results differ from our biological data yet may inadvertently support endogenous formation of at least some IEJs within DNA rather than requiring RNA. gencDNAs. An average of nine neurons per SAD brain were examined, raising immediate sampling issues required to detect mosaic APP gencDNAs. Self-identified "uneven genome amplification" (Kim et al. and [12] [13] [14] ) produces ~20% of the genome having less than 10X depth of coverage 14 with potential amplification failure at one (~9% allelic dropout rate) or both alleles (~2.3% locus dropout rate) 12, 14 . The limitations are compounded by potential amplification biases reflected by whole-genome amplification failure rates that may miss neuronal subtypes and/or disease states, especially relevant to single copies of APP gencDNAs that are as small as 0.15 kb Considering these many points, we believe that our data and conclusions supporting SGR and APP gencDNAs remain intact, warranting their further study in the normal and diseased brain.
Single-cell whole genome sequencing limitations may prevent APP gencDNA detection
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